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INTRODUCTION
Nowadays, dairy cows are capable of producing
enormous amounts of milk. From 1950 till now, milk
production has nearly quadrupled. This high level of
milk production is mainly enabled by a long-time ge-
netic selection towards higher milk production. How-
ever, the expression of this genetic potential is only
fully achieved when the cows are managed under op-
timal conditions. Deviations from these optimal condi-
tions easily result in an increased risk to develop health
problems, especially during the immediate postpartum
period.
Overconditioning at calving is one of the most im-
portant risk factors for modern dairy cows to develop
a range of health problems during the transition period
(Roche et al., 2009). The fat cow syndrome was first
described by Morrow (1976) as a combination of me-
tabolic, digestive, infectious and reproductive disorders
that affects obese periparturient dairy cows. 
Currently, a very similar syndrome receives attention
in human medicine mainly affecting obese people and
rendering them more susceptible to a range of health
problems,  with cardiovascular disease and type 2 dia-
betes mellitus as  the most important diseases. The syn-
drome has been named the metabolic syndrome, and
was formerly known as ‘the deadly quartet’ and ‘syn-
drome X’ (Cornier et al., 2008). The adipose tissue of
these obese patients seems to play a central role in the
pathophysiology of the syndrome by producing several
bioactive molecules, also known as adipokines (Hutley
and Prins, 2005).
The detrimental effects of obesity are not limited to
cows and humans. Obesity has been assigned as an im-
portant risk factor for the development of non-com-
municable diseases in different species. Obese dogs
and cats have a shorter life expectancy and are at in-
creased risk to develop diabetes mellitus, neoplasia, car-
dio-respiratory, gastro-intestinal, orthopedic and uro-
genital disorders (German et al., 2010; Zoran, 2010). In
horses, there is an important relationship between obe-
sity and the development of insulin resistance and la-
minitis (Geor, 2008; Frank, 2009). Postpartum dysga-
lactia in sows has been associated with different risk
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ABSTRACT
Overconditioning at calving is one of the most important risk factors for modern dairy cows to develop
diverse health problems during the transition period. Currently, the metabolic syndrome gains much attention
in human medicine. Research shows that the adipose tissue itself plays a crucial role in the increased
susceptibility of obese people to a range of health problems, with cardiovascular disease and type 2 diabetes
mellitus as the most important problems. The purpose of the present paper is to describe the human metabolic
syndrome and the fat cow syndrome with emphasis on both the similarities and differences. It may lead to a
better understanding of the pathophysiology of the fat cow syndrome, giving rise to innovative insights into
how to improve the management of modern dairy cows in the transition period.
SAMENVATTING
Vervetting rond het  moment van afkalven leidt bij melkkoeien vaak tot het ontstaan van het fat cow syndrome
en is een van de belangrijkste risicofactoren voor de ontwikkeling van gezondheidsproblemen bij deze koeien
gedurende de transitieperiode. Tegenwoordig wordt in de humane geneeskunde heel wat onderzoek verricht naar de
pathofysiologie van het zogenaamde metabool syndroom. Uit het onderzoek blijkt dat het vetweefsel van obese
mensen een cruciale rol speelt in de verhoogde gevoeligheid voor de ontwikkeling van verschillende
gezondheidsproblemen, waarvan cardiovasculaire aandoeningen en type 2 diabetes mellitus de belangrijkste zijn. Het
doel van dit artikel is om het humaan metabool syndroom en het fat cow syndrome te beschrijven met de nadruk op
de gelijkenissen en de verschillen tussen beide aandoeningen. Dit kan leiden tot de ontwikkeling van nieuwe inzichten
in de pathofysiologie van het fat cow syndrome en aldus tot een verbetering van het management van de moderne
melkkoe gedurende de transitieperiode teneinde de gezondheidstoestand van de dieren te optimaliseren.
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factors. One of these risk factors is the overconditio-
ning at parturition (Maes et al.¸ 2010). In accordance
with the human metabolic syndrome, it is supposed that
the adipose tissue provokes a derailment of the normal
physiological processes in obese animals, thereby ren-
dering them more susceptible to different health pro-
blems.
The purpose of the present paper is to describe the
human metabolic syndrome and the fat cow syndrome
with emphasis on both the similarities and differences. 
THE HUMAN METABOLIC SYNDROME
Situation and importance
The increasing prevalence of obesity is an important
health concern for the modern human population. The
World Health Organization (WHO) estimated that in
2008 at least 500 million adults were obese (body
mass index or BMI>30), whereas 1,5 billion adults
were overweight (BMI>25). Simultaneously, the pre-
valence of several obesity associated diseases, such as
type 2 diabetes mellitus and cardiovascular disease, is
increasing. A special term has been created to identify
obese people who are at high risk to develop type 2 dia-
betes mellitus and cardiovascular disease. This term is
called the metabolic syndrome (Cornier et al., 2008).
The metabolic syndrome was defined by the Interna-
tional Diabetes Federation (IDF): ‘for a person to be
defined as having the metabolic syndrome, he or she
must have:
• central obesity (waist circumference ≥ 94 cm for
European men and ≥ 80 cm for European women)
• plus two of the following four factors:
- raised triglyceride level (> 150 mg/dl)
- reduced HDL (high density lipoprotein) choles-
terol (< 40 mg/dl for men and < 50 mg/dl for wo-
men)
- raised blood pressure (systolic blood pressure ≥
130 mm Hg or diastolic blood pressure ≥ 85 mm
Hg)
- raised fasting plasma glucose (≥ 100 mg/dl) or
previously diagnosed type 2 diabetes mellitus’
(International Diabetes Federation, 2006).
The IDF estimates that 20-25% of the adult world
population can be classified as suffering from the me-
tabolic syndrome (International Diabetes Federation,
2006). Besides cardiovascular disease and type 2 dia-
betes mellitus, other conditions associated with obesity
and the metabolic syndrome are non-alcoholic fatty
liver disease, the polycystic ovarian syndrome, ob-
structive sleep apnea, hypogonadism, microvascular di-
sease, immune dysfunction and periodontitis (Marti et
al., 2001; Cornier et al., 2008; Bullon et al., 2009). 
At present, much attention is given to the role of the
adipose tissue in these obesity associated diseases,
with special emphasis on adipokines, non-esterified
fatty acids (NEFA’s), metaflammation (= a form of
chronic, low-level systemic inflammation, being linked
to the metabolic syndrome) and abdominal obesity
(Hotamisligil, 2006; Cornier et al., 2008; Després and
Lemieux, 2006; Lafontan and Berlan, 2003). 
Adipokines
Research on the role of adipose tissue in the patho-
genesis of the metabolic syndrome has revealed that the
adipose tissue is capable of secreting a wide range of dif-
ferent proteins, called adipokines (Pittas et al., 2004).
Up till now, more than 50 different adipokines have
been identified (Trayhurn and Wood, 2005). These
adipokines act locally (autocrine effect) or are secreted
in the peripheral circulation to have endocrine effects
(Prins, 2002). The adipose tissue of obese people pro-
duces more pro-inflammatory adipokines (TNF-α, IL6,
leptin, monocyte chemoattractant protein-1 or MCP-1)
and less anti-inflammatory adipokines (adiponectin).
The most important consequences of the altered se-
cretion of adipokines, as seen in obesity, are the in-
duction of a pro-inflammatory state, cardiovascular
damage and insulin resistance of the adipose tissue, the
liver and the skeletal muscle (Cornier et al., 2008)
(Table 1).
The pro-inflammatory state
Due to the altered production of adipokines, obese
people are considered to be in a pro-inflammatory
state with the adipose tissue itself as the primary site of
inflammation (Gustafson et al., 2007). This chronic
pro-inflammatory state is sometimes referred to as a
Table 1. List of the most important adipokines with their potential effects (Guerre-Millo, 2004; Meier and Gressner, 2004;
Wozniak et al., 2009).
Adipokine Potential effects
Leptin ↓ food intake, ↑ energy expenditure,
↑ insulin sensitivity, pro-inflammatory
Adiponectin ↑ insulin sensitivity, anti-inflammatory,
anti-atherogenic
Resistin pro-inflammatory, ↓ insulin sensitivity in rodents
(effect in humans not clearly identified)
TNF-α (Tumor necrosis factor α) ↓ insulin sensitivity, pro-inflammatory
IL-6 (Interleukin 6) ↓ insulin sensitivity, pro-inflammatory
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‘metaflammation’ or metabolically triggered inflam-
mation (Hotamisligil, 2006). The adipose tissue beco-
mes inflamed when an excessive amount of triglyceri-
des are stored in the adipocytes. Enlarged adipocytes
react to this stress by producing more pro-inflammatory
adipokines and less anti-inflammatory adipokines. This
results in an infiltration of macrophages in the adipose
tissue, which contributes to the production and se-
cretion of pro-inflammatory proteins (Cancello and
Clément, 2006; Gustafson et al., 2007) (Figure 1). In
addition, some of the hypertrophic adipocytes be-
come necrotic, which enhances a further infiltration of
macrophages (Cinti et al., 2005). 
The increased concentration of circulating NEFA as
typically observed during obesity contributes to the
production of pro-inflammatory adipokines by activa-
ting the inflammatory pathways in both adipocytes
and macrophages (Shi et al., 2006).
Interestingly, the pro-inflammatory state associated
with obesity increases the susceptibility to various in-
fections in obese people and animals (Dixit, 2008). In
obese dogs, mortality due to canine distemper virus has
been shown to be significantly increased (Bresnahan
and Newberne, 1968), while obese mice display a six
fold increase in mortality due to influenza virus infec-
tion (Smith et al., 2007).  However, the exact mecha-
nism by which obesity induces a pro-inflammatory
impaired immune status, is not yet fully elucidated.
NEFA
Besides the altered production of adipokines, the
obese body is also exposed to an elevated concentra-
tion of circulating NEFA (Lewis et al., 2002). NEFA
have direct and indirect effects on the health state of the
obese person: indirectly by stimulating the production
of adipokines, and directly by inducing insulin resi-
stance at the liver (increased gluconeogenesis), the
skeletal muscle (decreased glucose uptake) and the
adipose tissue (decreased glucose uptake and decrea-
sed inhibition of lipolysis by insulin) (Shi et al., 2006;
Jensen, 2006a; Lewis, 2002; Van Epps-Fung et al.,
1997). Chronic exposure of the pancreas to high NEFA
concentrations results in an impaired insulin secretion
by the β-cells (Jensen, 2006a). These alterations con-
tribute to the development of type 2 diabetes mellitus,
further harming the general health status of the obese
patient (Defronzo, 2004; Kahn et al., 2006).
Central or abdominal obesity
Basically, obese people can be divided into two
groups based on the location of fat accumulation. Some
people accumulate fat subcutaneously, mainly around
the hips and the lower part of the abdomen. This form
of obesity is called peripheral obesity. People suffering
from this type of fat accumulation are often referred to
as ‘the pears’, as their overall body shape has taken the
form of a pear. Others however accumulate fat subcu-
Figure 1. When the adipose tissue becomes ‘obese’, macrophages infiltrate the adipose tissue. Additionally, the adipose
tissue releases more NEFA’s and inflammatory adipokines, whereas the secretion of anti-inflammatory adipokines (adi-
ponectin) decreases (Gustafson et al., 2007).
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taneously at the upper part of the abdomen and in the
visceral depots (omentum, mesenterium). The latter
form of obesity is called central or abdominal obesity.
People suffering from this type of fat accumulation are
referred to as ‘the apples’ (Lafontan and Berlan, 2003). 
This distinction is of clinical importance because
especially the accumulation of visceral fat is associated
with an increased risk for obesity associated diseases,
whereas this is less the case for the accumulation of  sub-
cutaneous fat (Arner, 1998; Lafontan and Berlan, 2003).
This is also the reason why in the definition of the me-
tabolic syndrome as stated by the IDF (2006), waist cir-
cumference is included in favor of the body mass index
(BMI) as waist circumference reflects much better the
accumulation of fat in the abdomen. There are ethnic-
and sex-specific cut off values for this parameter, indi-
cating that the location where obese people store their
excessive amounts of fat, is both gender and race de-
pendent (IDF, 2006). It is generally known that men are
more at risk to acquire the apple like body shape when
they become obese, while obese women are more likely
to become pear like (Arner, 1997). 
There are some important functional differences
between these two forms of obesity. The visceral adi-
pose tissue has a higher lipolytic activity than the sub-
cutaneous adipose tissue. This is caused by a higher li-
polytic effect of catecholamines and a lower
antilipolytic effect of insulin at the visceral fat cells.
The resulting higher NEFA concentration in the vena
porta can lead to the development of hepatic insulin re-
sistance (Arner, 1998; Lafontan and Berlan, 2003; Jen-
sen, 2006b). Hepatic insulin resistance, characterized
by an increased gluconeogenesis, is a major contribu-
tor to the development of type 2 diabetes mellitus
(Scheen, 2003). 
Besides the higher lipolytic activity of the abdomi-
nal fat depots in abdominally obese persons, the pro-
duction of adipokines is also different in the visceral adi-
pocytes. In central obesity, the circulating concentration
of adiponectin, an anti-inflammatory adipokine, is de-
creased, whereas the expression and production of pro-
inflammatory adipokines, like TNF-α and IL6, are ele-
vated in comparison to those in peripherally obese
persons (Després and Lemieux, 2006). These factors in
combination with the more direct contact between the
visceral fat depots and the liver, generally renders ab-
dominally obese patients more susceptible to severe
health problems than peripherally obese people. 
THE FAT COW SYNDROME
Situation and importance
The fat cow syndrome was first described by Mor-
row (1976) as a combination of metabolic, digestive,
infectious and reproductive disorders that affects the
obese periparturient dairy cow. 
Overconditioned cows have a reduced appetite and
therefore a lower dry matter intake (DMI) prepartum
and a slower increase in postpartum DMI (Grummer et
al., 2004). As a consequence of this reduced DMI,
overconditioned cows start lactation in a more severe
negative energy balance (NEB) than their normal con-
ditioned counterparts (Grummer et al., 2004). 
Additionally, the adipose tissue of overfed cows
tends to be more sensitive to lipolytic and less sensitive
to antilipolytic stimuli (Rukkwamsuk et al., 1998).
The combination of a more severe NEB and a higher
lipolytic activity of the adipose tissue results in an ex-
cessive mobilization of NEFA in the overconditioned
periparturient dairy cow. A large proportion of the cir-
culating NEFA is taken up by the liver and is metabo-
lized in three ways: complete oxidation, partial oxida-
tion (ketogenesis) or re-esterification (Herdt, 2000;
Drackley et al., 2005). Firstly, the NEFA can be com-
pletely oxidized in the Krebs cycle with the production
of carbon dioxide and energy (ATP). For this reaction,
the hepatocytes need oxaloacetate. In periods of NEB
and high glucose requirements (late pregnancy, lacta-
tion), the precursor molecules for this oxaloacetate are
limited and the available oxaloacetate is preferentially
used as substrate for the gluconeogenesis. If the mo-
bilized NEFA are not completely oxidized, they are re-
directed to other metabolic pathways (Bell and Bau-
man, 1997; Bossaert et al., 2008b; Rukkwamsuk et al.,
1999a). Secondly, the NEFA can be partially oxidized
with the production of acetyl coenzyme A. This acetyl
coenzyme A is the precursor for the ketone bodies, ace-
toacetate, β-hydroxybutyrate and aceton (Herdt, 2000;
Bossaert et al., 2008b). Excessive production of ketone
bodies results in the development of (sub)clinical ke-
tosis. Thirdly, the hepatocytes can re-esterify the NEFA
with the production of triglycerides. These triglyceri-
des are secreted in the blood in very low density lip-
oproteins (VLDL), which consist of apoprotein B, tri-
glycerides, cholesterol, cholesterol-esters and
phospholipids. When the increased hepatic production
of triglycerides exceeds the hepatic synthesis of very
low density lipoproteins (VLDL), triglycerides are sto-
red in the parenchyma of the liver, which leads to he-
patic lipidosis or fatty liver (Rukkwamsuk et al., 1999a;
Herdt, 2000; Bossaert et al., 2008a). 
This is the well-known story of how a fat cow de-
velops fatty liver and ketosis. With the current know-
ledge of the role of the adipose tissue in the develop-
ment of obesity associated diseases in human medicine,
we can no longer ignore a possible role of the endocrine
function of the adipose tissue in the development of the
fat cow syndrome.
Comparison between the human metabolic syn-
drome and the fat cow syndrome
When comparing the human metabolic syndrome
with the fat cow syndrome, it is clear that there are a
lot of similarities: overconditioned cows are insulin re-
sistant (McCann and Reimers, 1985; Holtenius and
Holtenius, 2007), the adipose tissue of dairy cows is
also capable of producing different adipokines (Ing-
vartsen and Boisclair, 2001; Komatsu et al., 2003; Ko-
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matsu et al., 2005; Lemor et al., 2009; Mukesh et al.,
2010; Sadri et al., 2010), the disease susceptibility of
dairy cows is associated with a pro-inflammatory state
(Ohtsuka et al., 2001; Ametaj et al., 2005; Bertoni et
al., 2008; Bradford et al., 2009), the immunity of over-
conditioned cows is attenuated (Lacetera et al., 2005),
and overconditioned dairy cows are overall more sus-
ceptible to a variety of diseases (Morrow, 1976).
Apart from these similarities, there are some im-
portant differences between both syndromes. In human
medicine, obesity is associated with insulin resistance
(normoglycemia and secondary hyperinsulinemia) or
type 2 diabetes mellitus (hyperglycemia). Due to the
special carbohydrate metabolism in lactating dairy
cows, the glucose and insulin concentrations during
early lactation are low due to the high loss of glucose
through the production of milk (Herdt, 2000) (Table 2). 
NEFA in dairy cows
The physiological and pathological role of NEFA in
dairy cattle is well-studied. Triglycerides are the most
important energy reserve and are mobilized as NEFA
during NEB (Herdt, 2000). As long as the NEFA re-
lease from the adipose tissue is limited, this can be seen
as favorable since NEFA can directly or indirectly (as
ketone bodies) be used as energy substrate in different
tissues, thereby sparing glucose for milk production.
However, excessive fat mobilization results in an over-
load of NEFA with a negative impact on the produc-
tion, reproduction and insulin sensitivity (Pires et al.,
2007; Bossaert et al., 2008c). 
Especially in ruminants, an overload of NEFA ea-
sily surpasses the liver’s capacity to produce apopro-
tein B and VLDL. This leads to an increased amount
of triglycerides, being accumulated in the hepatocytes
(Gruffat et al., 1996). This fatty infiltration of the liver
impairs the hepatic metabolism, which results in a re-
duced activity of gluconeogenic enzymes (Ruk-
kwamsuk et al., 1999b). Since in cattle, the liver is the
primary site of glucose production, the reduced gluco-
neogenic activity results in a decreased glucose pro-
duction and a reduced milk production. 
Research at our department furthermore revealed
that high circulating concentrations of NEFA may reach
the follicular fluid in the ovary and have a detrimental
effect on the oocyte quality, which leads to poor in vi-
tro results regarding maturation, fertilization, cleavage
rate and blastocyst yield (Leroy et al., 2005). 
Additionally, overconditioned cows are more insu-
lin resistant than normal-conditioned cows (McCann
and Reimers, 1985; Holtenius and Holtenius, 2007).
Because overconditioned cows have a higher NEFA
blood concentration, a causative role is expected for
NEFA (Pires et al., 2007).      
Table 2. Comparison of the human metabolic syndrome and the fat cow syndrome (↑= increased; ↓ = decreased; ? = un-
known).
Property Human metabolic syndrome Fat cow syndrome References
Disease susceptibility ↑ ↑ Cornier et al. (2008)
Morrow (1976)
Adipokine ↑ ? Cornier et al. (2008)
production (except ↓ adiponectin) (except ↑ leptin and Ingvartsen and Boisclair (2001)
TNF-α) O’Boyle et al. (2006)
Gustafson et al., (2007)
Inflammation ↑ ↑ Ametaj et al., (2005)
O’Boyle et al., (2006)
Immune function ↓ ↓ Dixit (2008);
Lacetera et al., (2005)
Insulin sensitivity ↓ ↓ Cornier et al. (2008)
McCann and Reimers (1985)
Basal insulin Normal or ↑ Normal (low) Defronzo (2004), Herdt (2000)
concentration
Glucose stimulated Normal, ↑ or ↓ ? Defronzo (2004)
insulin response
Glucose concentration ↑ or normal Normal (low) Defronzo (2004), Herdt (2000)
Obesity Visceral ? Després and Lemieux (2006)
76 Vlaams Diergeneeskundig Tijdschrift, 2012, 81
In vivo and in vitro research in humans and in ro-
dents has shown that NEFA directly inhibit the insulin
signaling pathway in the skeletal muscle, the liver and
the adipose tissue (Boden and Shulman, 2002; Van
Epps-Fung, 1997). This was confirmed by an in vivo
research in dairy cows where it was demonstrated that
artificial (iatrogenic) induction of elevated NEFA con-
centrations causes insulin resistance (Pires et al., 2007).
In fact, insulin resistance entails a lower glucose uptake
in the skeletal muscle and the adipose tissue. This is fa-
vorable, since it increases the glucose availability for
milk production. However, the insulin mediated inhi-
bition of the hormone sensitive lipase at the adipose tis-
sue may be attenuated, which may result in a further
increase of the NEFA levels (Pires et al., 2007).
As in humans, the secretion of insulin by the
pancreas in dairy cows, sometimes seems to be
seriously compromised. In a study in which cows,
previously diagnosed with cystic ovarian disease, were
submitted to an intraveneous glucose tolerance test,
Opsomer et al. (1999) found three cystic cows that did
not react with an increased insulin secretion following
the administration of an intraveneous glucose bolus. In
none of the matched control cows, a similar absence of
insulin secretion could be detected. A similar absence
of insulin secretion following the administration of a
glucose bolus in dairy cows was demonstrated by Hove
(1978) in ketonemic and starved cows. Recently,
Bossaert et al. (2008c) demonstrated that the insulin
secretion following the administration of an
intraveneous glucose bolus is negatively associated
with the level of NEFA that cows had experienced in
the periparturient period. This leads us to conclude that
in dairy cows as well as in humans, some individuals
have susceptible β-cells whose function becomes
seriously depressed by chronically elevated NEFA
levels. As differences in pancreatic insulin secretion
following an intraveneous glucose bolus have already
been demonstrated in neonatal calves, this β-cell
susceptibility has been hypothesized to have a(n)
(epi)genetic background (Bossaert et al., 2009).
Adipokines in dairy cows
The altered production of adipokines by the visce-
ral fat depots seems to be the key factor in the develop-
ment of health problems in abdominally obese persons. 
Research towards gene expression in adipose tissue
of dairy cows has confirmed the role of the adipose tis-
sue as an endocrine organ. Different studies have de-
monstrated an expression of mRNA for TNF-α, IL6,
MCP1, leptin, adiponectin, visfatin and resistin in the
adipose tissue of dairy cows (Ingvartsen and Bois-
clair, 2001; Komatsu et al., 2003; Komatsu et al.,
Figure 2. Average amount (in kg) of fat in the different fat depots of dairy cows slaughtered at different stages in the
lactation cycle (four cows slaughtered per stage). Change (in %) of the size of the different fat depots relative to the pre-
vious point in time of each individual fat depot (Butler-Hogg et al., 1985).
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2005; Lemor et al., 2009; Mukesh et al., 2010; Sadri
et al., 2010).
To the best of our knowledge, the exact function of
most of the adipokines in dairy cows are unknown, ex-
cept for leptin. Leptin is an important regulator of feed
intake and influences the adaptational mechanisms du-
ring the transition period. However, there are also in-
dications that leptin may influence the reproductive and
immune systems (Ingvartsen and Boisclair, 2001). For
leptin, it is known that the plasma concentration in
dairy cows is influenced by BCS and energy balance,
with a higher plasma concentration in cows with a
high BCS and a lower plasma concentration during
early lactation (Ingvartsen and Boisclair, 2001; Meikle
et al., 2004).  For adiponectin, a possible role in the
adaptational mechanism is expected because of the
increase in the plasma concentration during the first
weeks of lactation. It reaches a maximum value at four
weeks post partum. Subsequently, the value declines
and remains stable from the fifth till the eleventh week
post partum. In contrast with human adiponectin, in
dairy cows no influence of the BCS on the plasma con-
centration of adiponectin can be observed. However,
these values are generated using a human radioimmu-
noassay kit and may not accurately reflect the real
plasma concentrations of adiponectin in dairy cows
(Raddatz et al., 2008).
For TNF-α, it has been demonstrated that cows with
a BCS > 3.5 tend to have a higher plasma TNF-α con-
centration than cows with a normal BCS (BCS 2.5-2.7)
during mid-lactation (O’Boyle et al., 2006). Additio-
nally, increased serum TNF-α concentrations have been
shown to be associated with insulin resistance and the
development of fatty liver (Ohtsuka et al., 2001; Brad-
ford et al., 2009). 
The pro-inflammatory state in dairy cows
A recent study in dairy cows demonstrated a nega-
tive correlation between sustained low plasma con-
centration of negative acute phase proteins during lac-
tation and health and fertility problems (Bertoni et al.,
2008). The cows with chronically low concentrations
of negative acute phase proteins, as measured by the
average plasma concentration of albumin, cholesterol
and retinol-binding protein at 7, 14 and 28 days in milk
(DIM), had also the highest plasma concentration of
haptoglobin, a positive acute phase protein. The cows
with chronically low concentrations of negative acute
phase proteins had a higher frequency of health (dys-
tocia, milk fever, retained placenta, ketosis, lameness,
mastitis) and fertility problems (Bertoni et al., 2008).
Other studies confirm these observations by demon-
strating a strong positive correlation between positive
acute phase proteins and cytokines and the develop-
ment of fatty liver post partum (Ohtsuka et al., 2001;
Ametaj et al., 2005; Bradford et al., 2009). 
These data suggest a role for chronic low-grade in-
flammation in several diseases that occur during the
transition period. 
Immune function and overconditioning in dairy
cows
The association between overconditioning and the
elevated incidence of infectious diseases has been ex-
plained by an impaired immune function in overcon-
ditioned cows. In the periparturient period, it is obser-
ved that the lymphocyte function is attenuated in
overconditioned cows (Lacetera et al., 2005). More-
over, overconditioned cows have higher circulating
concentrations of reactive oxygen metabolites and lo-
wer circulating concentrations of antioxidants (Berna-
bucci et al., 2005). This increased oxidative stress may
be an important cause of an attenuated immune func-
tion (Sordillo and Aitken, 2009). 
BCS and abdominal obesity
In dairy cows, body condition scoring (BCS) and the
ultrasonographic measurement of back fat thick-ness are
practical methods to describe the energy reserve at a spe-
cific point in time in the lactation cycle (Schröder and
Staufenbiel, 2006). By comparing the BCS of one and
the same cow at different points in time, it is possible to
have an idea of the energy balance over that period in
that specific cow. The BCS system as used in dairy
cattle is based on the subjective visual and/or tactile eva-
luation of the amount of subcutaneously stored fat at the
lumbar, sacral and tail region (Bewley and Schutz,
2008). 
The total amount of fat stored in the body of dairy
cows can be divided into different fat depots depen-
dent on the localization. The largest amount of body
fat can be found intermuscularly (50%), followed by
subcutaneous fat (15-20%), omental fat (10%), peri-
renal-retroperitoneal fat (10%), mesenteric fat (7%-
8%) and fat stored in other parts of the body (Butler-
Hogg et al., 1985). Hence, by assessing the BCS, only
15-20% of the total body fat, being the subcutaneous
fat, is evaluated. There is a positive correlation between
the BCS, the total amount of body fat and the amount
of fat stored in the individual fat depots. Nevertheless,
not all fat depots are mobilized or replenished at the
same time, at the same magnitude (Butler-Hogg et al.,
1985). During early lactation in dairy cows, relatively
more fat is mobilized from the subcutaneous and peri-
renal-retroperitoneal fat depots than from the inter-
muscular, omental and mesenteric fat depots (Butler-
Hogg et al., 1985) (Figure 2). 
In a recent study, overfeeding non-pregnant dry
Holstein cows resulted in a significant increase of
omental, mesenteric and perirenal fat without changes
in BCS (Nikkhah et al., 2008). This implies that a cow
can have a normal body condition score even though
she possesses a large amount of ‘invisible’ abdominal
fat stored in the mesenterium and the omentum (Van
Eetvelde et al., 2011). Additionally, dairy cows seem
to have a genetic tendency to accumulate more fat in
the intra-abdominal depot and less fat in the subcuta-
neous depot (Wright and Russel, 1984). In human me-
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dicine, the accumulation of fat in the abdomen is lin-
ked to an increased disease susceptibility. Whether the
same holds true for dairy cows remains an open ques-
tion.
CONCLUSION
The recent developments in research on the patho-
physiology of the metabolic syndrome in human me-
dicine have revealed an important endocrine function
of the adipose tissue. The adipose tissue is no longer
considered to be only a storage place for excess energy;
it is also capable of secreting a wide array of bioactive
molecules, named adipokines. These adipokines seem
to be the missing link between obesity, cardiovascular
disease and insulin resistance in human medicine. 
In dairy cows, in which overconditioning at calving
means an increased risk for reproductive, infectious
and metabolic disorders in the transition period, we can
no longer ignore the secretory capacity of the adipose
tissue. This new perspective on the role of the adipose
tissue in these disorders highlights the importance of
monitoring the BCS during the lactation cycle and gi-
ves new opportunities for the treatment and manage-
ment of the transition cow. 
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Aart de Kruif schrijft in zijn boek ‘Typisch testos-
teron” over de invloed van testosteron op het gedrag
van mannen en vrouwen.
Hij stelt dat die invloed vele malen groter is dan we
vermoeden. Door zijn onderzoek en kennis van het ge-
drag bij dieren raakte hij gefascineerd door de grote
overeenkomsten tussen dierlijk en menselijk gedrag,
met name wat de werking betreft van dit ene hormoon.
Hij stelt op basis van wetenschappelijk onderzoek dat
biologische factoren, zoals hormonen, vaak een veel
sterker effect hebben op gedrag dan sociologische of
culturele factoren. Hij neemt daarbij een duidelijk, voor
sommigen misschien controversieel, standpunt in.
Lang vóór zijn geboorte is bepaald of een man met
een hoog of laag testosterongehalte door het leven zal
gaan. Mannen met een hoog testosterongehalte hebben
een hoger libido, ze zijn dominanter en hebben meer
energie. Mannen met een lagere testosteronconcentra-
tie zijn socialer en meer teamplayers.
In dit zeer interessante boek is alles over de impact
van testosteron verzameld; het genot, de noodzaak en
de nadelen. Zonder testosteron geen vooruitgang, maar
waarschijnlijk ook geen oorlogen en veel minder cri-
minaliteit, aldus Aart de Kruif.
Kortom, een boek dat iedereen zou moeten lezen.
Nadia Eeckhout
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